Opdivo/Cabometyx Combo ‘Very Encouraging' In 1L RCC

But Competition Intensifying

 
• By Ian Haydock
  
Kidney cancer
New Opdivo Combo Looks Good In RCC • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer